Radiation plus immunotherapy for glioblastoma patients
Part of Cancer clinical trials.
This trial tests a combination of radiation and immunotherapy for people with glioblastoma. The goal is to see if adding immunotherapy to standard radiation can improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of glioblastoma, an aggressive brain tumor.
- Your daily activity level is good (score 0, 1, or 2 on a standard scale).
- Your brain tumor can be surgically removed based on your neurosurgeon's guidelines.
- You have not had a stroke before.
- You do not have another primary cancer or cancer that has spread to other parts of your body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests combining an immunotherapy drug (adebrelimab) with the standard chemotherapy temozolomide, with or without hyperbaric oxygen treatment, for patients with newly diagnosed glioblastoma who have already completed standard radiation and chemotherapy. The goal is to see if this combination can improve outcomes.
This trial tests whether adding a special type of radiofrequency electromagnetic field treatment to standard chemotherapy and radiation therapy helps people with newly diagnosed glioblastoma. It is for patients who are planning to receive standard treatment and have had surgery to remove the tumor.
This trial tests giving radiation and chemotherapy before surgery for glioblastoma. It aims to see if this approach is safe and may help improve outcomes for patients whose tumor can be completely removed.
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
This trial compares two ways of giving radiation—standard photon radiotherapy (IMRT) versus proton beam therapy—for people with glioblastoma. It may help find a safer or more effective radiation approach for shrinking tumors and improving outcomes.
This trial tests whether adding an experimental drug called liposomal transcrocetin (L-TC) to the standard treatment of radiation and temozolomide chemotherapy helps people with newly diagnosed glioblastoma. It aims to see if the combination improves outcomes compared to standard care alone.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.